M
Martha Skinner
Researcher at Boston University
Publications - 289
Citations - 17943
Martha Skinner is an academic researcher from Boston University. The author has contributed to research in topics: Amyloidosis & AL amyloidosis. The author has an hindex of 69, co-authored 289 publications receiving 16916 citations. Previous affiliations of Martha Skinner include Beth Israel Deaconess Medical Center & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Reduction in ventricular wall thickness following high-dose chemotherapy and stem-cell transplantation for al cardiac amyloidosis
Frederick L. Ruberg,Vaishali Sanchorawala,John L. Berk,Kathleen T. Finn,Martha Skinner,David C. Seldin,Hans K. Meier-Ewert +6 more
results of a phase II trial Lenalidomide and dexamethasone in the treatment of AL amyloidosis
B Zeldis,Martha Skinner,David C. Seldin,Vaishali Sanchorawala,Michael Rosenzweig,Kathleen T. Finn,Salli Fennessey +6 more
Journal ArticleDOI
Successful Treatment of AL Amyloidosis Patients over Age 65 with High-Dose Melphalan and Autologous Stem Cell Transplantation (HDM/SCT).
David C. Seldin,David C. Seldin,Jennifer J. Anderson,Martha Skinner,Martha Skinner,Karim Malek,Karim Malek,Daniel G. Wright,Daniel G. Wright,Karen Quillen,Vaishali Sanchorawala,Vaishali Sanchorawala +11 more
TL;DR: In this paper, the authors presented a detailed analysis of outcomes in patients >65 vs. those 65 for AL amyloidosis and showed that for those who do meet eligibility requirements for HDM/SCT, treatment-related mortality, hematologic complete response rate, and survival are no different than for younger patients.
Journal ArticleDOI
Early Serum Free Light Chain Responses Following High-Dose Melphalan and Stem Cell Transplantation for AL Amyloidosis Predict Treatment Outcomes.
Vaishali Sanchorawala,Daniel G. Wright,Karen Quillen,Catherine Fisher,Martha Skinner,David C. Sedlin +5 more
TL;DR: In conclusion, meaningful quantitative FLC responses (or lack of response) can be detected within weeks following HDM/SCT treatment that predict hematologic responses, as defined subsequently by standard criteria based on IFE and marrow studies.